Cloning and Characterization of a Novel Six-Transmembrane Protein STEAP2, Expressed in Normal and Malignant Prostate

Autor: Porkka, Kati P, Helenius, Merja A, Visakorpi, Tapio

Publikováno v: In Laboratory Investigation 1 November 2002 82(11):1573-1582

Amplification of the urokinase gene and the sensitivity of prostate cancer cells to urokinase inhibitors.

Autor: Helenius, Merja A.¹, Savinainen, Kimmo J.¹, Bova, G. Steven², Visakorpi, Tapio¹ tapio.visakorpi@uta.fi

Publikováno v: BJU International. Feb2006, Vol. 97 Issue 2, p404-409. 6p. 4 Graphs.

CIP2A is a candidate therapeutic target in clinically challenging prostate cancer cell populations

Autor: Khanna, Anchit, Rane, Jayant K., Kivinummi, Kati K., Urbanucci, Alfonso, Helenius, Merja A., Tolonen, Teemu T., Saramäki, Outi R., Latonen, Leena, Manni, Visa, Pimanda, John E., Maitland, Norman J., Westermarck, Jukka, Visakorpi, Tapio

Publikováno v: Khanna, Anchit Rane, Jayant K. Kivinummi, Kati K. Urbanucci, Alfonso Helenius, Merja A. Tolonen, Teemu T. Saramäki, Outi R. Latonen, Leena Manni, Visa Pimanda, John E. Maitland, Norman J. Westermarck, Jukka Visakorpi, Tapio . CIP2A is a candidate therapeutic target in clinically challenging prostate cancer cell populations. OncoTarget. 2015, 6(23), 19661-19670
OncoTarget

Externí odkaz: http://hdl.handle.net/10852/56773
https://www.duo.uio.no/bitstream/handle/10852/56773/1/3875-51510-3-PB.pdf

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Somatic Genetic Changes in Prostate Cancer.

Autor: Markman, Maurie, Pestell, Richard G., Nevalainen, Marja T., Milken, Michael, Helenius, Merja A., Waltering, Kati K., Visakorpi, Tapio

Publikováno v: Prostate Cancer (978-1-58829-741-9); 2008, p99-128, 30p